1. Home
  2. NTHI
  3. NTHI News

Latest NeOnc Technologies Holdings Inc. Common Stock (NTHI) News on June 21, 2025

NTHI

Argus Research

a day ago

Daily – Vickers Top Insider Picks for 06/20/2025

NTHI

Argus Research

3 days ago

Daily – Vickers Top Insider Picks for 06/18/2025

NTHI

Argus Research

4 days ago

Daily – Vickers Top Insider Picks for 06/17/2025

NTHI

Argus Research

5 days ago

Daily – Vickers Top Insider Picks for 06/16/2025

NTHI

Argus Research

8 days ago

Daily – Vickers Top Insider Picks for 06/13/2025

NTHI

Argus Research

9 days ago

Daily – Vickers Top Insider Picks for 06/12/2025

NTHI

Argus Research

10 days ago

Daily – Vickers Top Insider Picks for 06/11/2025

NTHI

Argus Research

11 days ago

Daily – Vickers Top Insider Picks for 06/10/2025

NTHI

MT Newswires

12 days ago

NeOnc Technologies Files Prospectus for Resale of Shares

NTHI

Argus Research

12 days ago

Daily – Vickers Top Insider Picks for 06/09/2025

NeOnc Technologies Holdings, Inc. Appoints Dr. Josh Neman as Chief Clinical Officer to Advance Clinical Strategy and Translational Oncology Programs
NTHI

GlobeNewswire

15 days ago

NeOnc Technologies Holdings, Inc. Appoints Dr. Josh Neman as Chief Clinical Officer to Advance Clinical Strategy and Translational Oncology Programs

NTHI

Argus Research

15 days ago

Daily – Vickers Top Insider Picks for 06/06/2025

NTHI

Argus Research

16 days ago

Daily – Vickers Top Insider Picks for 06/05/2025

NTHI

Argus Research

17 days ago

Daily – Vickers Top Insider Picks for 06/04/2025

NTHI

Argus Research

18 days ago

Daily – Vickers Top Insider Picks for 06/03/2025

NTHI

Argus Research

19 days ago

Daily – Vickers Top Insider Picks for 06/02/2025

NTHI

Argus Research

22 days ago

Daily – Vickers Top Insider Picks for 05/30/2025

NTHI

Argus Research

23 days ago

Daily – Vickers Top Insider Picks for 05/29/2025

NTHI

Argus Research

24 days ago

Daily – Vickers Top Insider Picks for 05/28/2025

NTHI

Argus Research

25 days ago

Daily – Vickers Top Insider Picks for 05/27/2025

NTHI

MT Newswires

2 months ago

Top Premarket Decliners

NeOnc Technologies Global Patent Portfolio Covers Core Pipeline Across All Major Pharmaceutical Markets
NTHI

GlobeNewswire

2 months ago

NeOnc Technologies Global Patent Portfolio Covers Core Pipeline Across All Major Pharmaceutical Markets

NTHI

MT Newswires

2 months ago

NeOnc Technologies Expects Full Enrollment in Phase 2a Trialfor NEO100-01 by September

NeOnc Technologies Holdings, Inc. Expects Full Enrollment in Promising Phase 2a Trial of NEO100-01 for Malignant Gliomas in September
NTHI

GlobeNewswire

2 months ago

NeOnc Technologies Holdings, Inc. Expects Full Enrollment in Promising Phase 2a Trial of NEO100-01 for Malignant Gliomas in September

NTHI

MT Newswires

2 months ago

NeOnc Technologies Appoints Executive Chairman Amir Heshmatpour as President

NeOnc Technologies Holdings, Inc. Executive Chairman, Amir Heshmatpour, Assumes Expanded Leadership Role as Company’s New President
NTHI

GlobeNewswire

2 months ago

NeOnc Technologies Holdings, Inc. Executive Chairman, Amir Heshmatpour, Assumes Expanded Leadership Role as Company’s New President

NTHI

MT Newswires

2 months ago

Sector Update: Health Care Stocks Fall Premarket Wednesday

NTHI

MT Newswires

2 months ago

NeOnc Technologies Phase 1 Trial Enrollment for NEO212 Brain Cancer Drug Nears Full Enrollment

NeOnc Technologies Announces Near Completion of Phase I Enrollment for NEO212 Brain Cancer Therapy
NTHI

GlobeNewswire

2 months ago

NeOnc Technologies Announces Near Completion of Phase I Enrollment for NEO212 Brain Cancer Therapy

NTHI

MT Newswires

3 months ago

NeOnc Technologies Holdings' Perillyl Alcohol Receives FDA's Rare Pediatric Disease Designation

NeOnc Technologies Holdings, Inc. Receives Rare Pediatric Disease Designation for NEO100 in Treatment of Pediatric-Type Diffuse High-Grade Gliomas
NTHI

GlobeNewswire

3 months ago

NeOnc Technologies Holdings, Inc. Receives Rare Pediatric Disease Designation for NEO100 in Treatment of Pediatric-Type Diffuse High-Grade Gliomas

NeOnc Technologies Expands Global Clinical Trial Network with CBCC Global Research to Accelerate Study of Brain Cancer Treatments
NTHI

GlobeNewswire

3 months ago

NeOnc Technologies Expands Global Clinical Trial Network with CBCC Global Research to Accelerate Study of Brain Cancer Treatments

Share on Social Networks: